Adicet Bio
ACET
ACET
56 hedge funds and large institutions have $42M invested in Adicet Bio in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
24% less capital invested
Capital invested by funds: $55.4M → $42M (-$13.4M)
41% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 22
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
Holders
56
Holding in Top 10
2
Calls
$34K
Puts
$14K
Top Buyers
| 1 | +$927K | |
| 2 | +$116K | |
| 3 | +$58.6K | |
| 4 |
Goldman Sachs
New York
|
+$48.1K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$27.4K |
Top Sellers
| 1 | -$446K | |
| 2 | -$258K | |
| 3 | -$157K | |
| 4 |
Squarepoint
New York
|
-$130K |
| 5 |
Two Sigma Advisers
New York
|
-$129K |